현재 위치
Home
[원보]
우리나라 건강보험 청구자료를 이용한 알츠하이머성 치매 치료제의 사용현황 분석
Study of the Drugs Prescribed on Alzheimer's Disease: from the Insurance Claims Data of Korea National Health Insurance Service
-
- 발행기관
- 한국임상약학회 바로가기
-
- 간행물
- 한국임상약학회지 KCI 등재 바로가기
-
- 통권
- 제24권 제4호 (2014.12)바로가기
-
- 페이지
- pp.255-264
-
- 저자
-
- 언어
- 한국어(KOR)
-
- URL
- https://www.earticle.net/Article/A238903
※ 기관로그인 시 무료 이용이 가능합니다.
4,000원
원문정보
초록
- 영어
- Objective: The aims of this study are to investigate the total volume of prescribed medicines against Alzheimer’s disease(AD) and the trends of usage by analyzing the claims-data from the Korea National Health Insurance Service. Method: The demographic and claims-data were included the major AD treating medicines such as donepezil, galantamine,rivastigmine and memantine, and analyzed during the period of 2010~2012. The assessing criteria were gender,age, habitation, types of medical institution, code of ingredients, outcomes of treatment, volume and amount of claims,and the numbers of patients with dementias. After trimming the data, it were analyzed by the market size, demographictraits, characteristics of medical service, characteristics of each anti-AD medicine, etc. Results: Among the chosen4 medicines, donepezil had the top prescription volumes. Most prevalent prescribing preparations of donepezil wereconventional types. However, among the non-conventional types, oro-dispersible formulation is the fast increasing onein both volume and growth rate. This specialized preparations to improve both toleration and adherence, tend to beingprescribed generally at the tertiary medical institutions. While the younger patients with mild-to-moderate AD mostlytreated by expensive medicines in resident at the tertiary hospitals, the rest older patients with severe AD have beentreated non-expensive one at long-term care facilities. Conclusion: AD is a chronic illness therefore, long-term use oftherapeutic medications are highly important. If an anti-AD treatment was applied steadily in the earlier stages, it wouldbe achieved not only improving the quality of life of patient but also reducing the expenses in the medical and nursingcares. As the socioeconomical impacts of AD is expanding, healthcare professionals need to aware the importance ofpharmacotherapy and to improve sociopolitical fundamentals.
목차
Abstract
연구 방법
연구자료
연구대상
연구방법
연구 결과
약제의 총 사용규모
인구학적 특성
의료서비스 이용 특성
약제별 경향
고찰
결론
감사의 글
참고문헌
키워드
Alzheimer's disease claims data donepezil galantamine rivastigmine memantine저자
간행물 정보
발행기관
-
- 발행기관명
- 한국임상약학회 [Korean College of Clinical Pharmacy]
- 설립연도
- 1
- 분야
- 의약학>약학
- 소개
- 합리적 약물치료(rational pharmacotherapy)의 보장 및 증진을 궁극목적으로 하며 이를 달성하기 위해 임상약학의 발전과 회원 상호간의 친목을 도모한다.
간행물
-
- 간행물명
- 한국임상약학회지 [Korean Journal of Clinical Pharmacy]
- 간기
- 계간
- pISSN
- 1226-6051
- 수록기간
- 1991~2026
- 등재여부
- KCI 등재
- 십진분류
- KDC 518 DDC 615
이 권호 내 다른 논문 / 한국임상약학회지 제24권 제4호
피인용수 : 0건 (자료제공 : 네이버학술정보)
함께 이용한 논문 이 논문을 다운로드한 분들이 이용한 다른 논문입니다.
출처 : 네이버학술정보
0개의 논문이 장바구니에 담겼습니다.